论文部分内容阅读
本研究旨在确定在行直接或补救性经皮冠状动脉介入(PCI)的ST段抬高型急性心肌梗死(STEMI)患者中,与手法压迫止血相比,应用经皮动脉闭合装置(ACD)是否会影响出血并发症。回顾性评价连续314例接受PCI治疗的STEM I患者。总体而言,82.8%的患者接受ACD,其总出血率为4.2%,而接受手法压迫止血的患者中出血率为11.1%(P=0.042)。出血率的差异与任何临床特征或使用G P IIb/IIIa拮抗剂与否无关。据此推测,ACD可改善STEM I患者PCI治疗后的急性结局。
The aim of this study was to determine whether percutaneous arterial closure (ACD) is more effective than manual oppression in patients with ST-elevation acute myocardial infarction (STEMI) undergoing direct or salvage percutaneous coronary intervention (PCI) Will it affect bleeding complications? A total of 314 consecutive STEM I patients undergoing PCI were retrospectively evaluated. Overall, 82.8% of patients received ACD with a total bleeding rate of 4.2%, compared with 11.1% (P = 0.042) in patients undergoing oppression and hemostasis. Differences in bleeding rates were not associated with any clinical features or with G P IIb / IIIa antagonists. According to this speculation, ACD can improve STEM I patients with acute outcomes after PCI.